GSK576428

fondaparinux · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK576428, covering 2017-10-11 to 2017-10-11. Get the full timeline:

Most recent: Clinical Trial Update: Hip Fracture Study of GSK576428 (Fondaparinux Sodium) [Phase 3]